CRSP icon

CRISPR Therapeutics

395 hedge funds and large institutions have $2.45B invested in CRISPR Therapeutics in 2022 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 117 increasing their positions, 120 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
395
Holders Change
-39
Holders Change %
-8.99%
% of All Funds
6.37%
Holding in Top 10
3
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-62.5%
% of All Funds
0.05%
New
56
Increased
117
Reduced
120
Closed
87
Calls
$109M
Puts
$86.2M
Net Calls
+$23.2M
Net Calls Change
+$12.7M
Name Holding Trade Value Shares
Change
Shares
Change %
First Manhattan
351
First Manhattan
New York
$2.03K
WBC
352
West Branch Capital
Massachusetts
$2.03K
LFA
353
Level Financial Advisors
New York
$2K
PS
354
PayPay Securities
Japan
$1.83K +$1.83K +45 New
TFP
355
Tilia Fiduciary Partners
North Carolina
$1.71K
RWPA
356
Richard W. Paul & Associates
Michigan
$1.71K +$1.71K +42 New
AIM
357
Anchor Investment Management
South Carolina
$1.63K -$4.07K -100 -71%
SIC
358
SJS Investment Consulting
Ohio
$1.38K
LC
359
Lindbrook Capital
California
$1.34K +$650 +16 +94%
ME
360
McIlrath & Eck
Washington
$1.26K
PP
361
Pacifica Partners
Canada
$1.23K
IGWM
362
ICA Group Wealth Management
Colorado
$1.22K +$1.22K +30 New
EWA
363
EverSource Wealth Advisors
Alabama
$1.02K -$14.5K -356 -93%
GI
364
Gradient Investments
Minnesota
$1.02K
CT
365
Colonial Trust
South Carolina
$1.02K +$1.02K +25 New
KA
366
Kozak & Associates
Colorado
$1K
ADL
367
Asset Dedication LLC
California
$1K
IFAM
368
Institutional & Family Asset Management
Colorado
$854
JWM
369
Janiczek Wealth Management
Colorado
$844
TFM
370
TFC Financial Management
Massachusetts
$813
NC
371
NewSquare Capital
Pennsylvania
$813 +$813 +20 New
CAS
372
Coppell Advisory Solutions
Texas
$813 +$813 +20 New
CASC
373
Coppell Advisory Solutions Corp
Texas
$813 +$813 +20 New
KFI
374
Key Financial Inc
Pennsylvania
$784
NMG
375
New Millennium Group
Utah
$650